FDA Approved: SIMBRINZA — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application for SIMBRINZA (brinzolamide/brimonidine tartrate) submitted by Alcon Laboratories, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Simbrinza (brinzolamide/brimonidine)

Snippet

SUPPL AP for SIMBRINZA (BRINZOLAMIDE/BRIMONIDINE TARTRATE)